Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minireview: the OPG/RANKL/RANK system.

S Khosla1

  • 1Endocrine Research Unit, Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA. khosla.sundeep@mayo.edu

Endocrinology
|November 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women's Musculoskeletal Health: Insights from the 2024 National Academies of Sciences, Engineering, and Medicine Report on Chronic Conditions.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Same author

Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
Same author

Peri-operative complications of sphenopalatine artery ligation: a 10-year series from two secondary care centres.

The Journal of laryngology and otology·2022
Same author

1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.

Neuromuscular disorders : NMD·2021
Same author

Ex vivo normothermic perfusion of isolated segmental porcine bowel: a novel functional model of the small intestine.

BJS open·2021
Same journal

Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesity.

Endocrinology·2026
Same journal

Long Non-Coding RNAs Mediate Endocrine Signaling and Resistance in Prostate Cancer.

Endocrinology·2026
Same journal

Repeated Chemogenetic Activation of C1 Catecholamine Neurons Reduces Subsequent Glucoprivic Responses and Mimics HAAF.

Endocrinology·2026
Same journal

Postnatal exposure to maternal hypothyroidism leads to developmental delay and metabolic dysregulations in male mice.

Endocrinology·2026
Same journal

Discovery proteomics identification of factors contributing to gonadotropin β expression.

Endocrinology·2026
Same journal

3D genome architecture and epigenetic regulation of lineage identity in advanced prostate cancer.

Endocrinology·2026
See all related articles

The OPG/RANKL/RANK system is key to bone formation and breakdown. Understanding this pathway offers insights into osteoporosis and other bone disorders.

Area of Science:

  • Bone Biology
  • Cell Signaling
  • Endocrinology

Background:

  • Osteoclastogenesis, the process of forming osteoclasts, was long studied to find its key regulators.
  • The discovery of the OPG/RANKL/RANK system marked a significant breakthrough in understanding bone metabolism.

Purpose of the Study:

  • To elucidate the role of the OPG/RANKL/RANK system in osteoclastogenesis.
  • To explore the regulation and signaling pathways of RANKL/RANK.
  • To investigate the system's involvement in metabolic bone disorders.

Main Methods:

  • Cloning and characterization of OPG and RANKL.
  • Analysis of RANKL binding to its receptor RANK.
  • Examination of skeletal phenotypes in genetically modified mice.

Related Experiment Videos

Main Results:

  • OPG (osteoprotegerin) functions as a decoy receptor.
  • RANKL (RANK ligand) is essential for osteoclast development, existing in membrane-bound and soluble forms.
  • Genetic alterations in OPG/RANKL/RANK led to extreme skeletal phenotypes in mice, confirming their regulatory role.

Conclusions:

  • The OPG/RANKL/RANK system is the primary regulator of osteoclastogenesis.
  • Further research focuses on factors influencing this system and its implications for bone diseases like osteoporosis.